Literature DB >> 27326018

The relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein.

Hidekazu Takeuchi1, Masataka Sata1.   

Abstract

OBJECTIVE: To study the relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein.
DESIGN: A retrospective, cross-sectional study.
SETTING: Tokushima University Hospital area. PATIENTS: A retrospective study of 46 patients (nine inpatients and 37 outpatients) with angina pectoris or arrhythmias who were seen at Tokushima University Hospital Cardiovascular Division and had measurements of their BNP, fatty acid and lipid profile. The average age of patients was 57±17 years, and 39% were male subjects. MAIN OUTCOME MEASURES: BNP, dihomo-γ-linolenic acid, arachidonic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), apolipoproteinA1, apolipoprotein A2 (ApoA2), apolipoprotein B (ApoB), apolipoprotein C2, apolipoprotein C3, apolipoprotein E, total cholesterol (TC), triglyceride, high density lipoprotein cholesterol and low density lipoprotein cholesterol.
RESULTS: The baseline characteristics of the patients were shown in table 1 and the data of lipoprotein were shown in table 2. Table 3 shows the relationship among BNP, cholesterol and lipoprotein. The authors found significant negative correlation between serum levels of BNP and ApoA2 (figure 1; r=-0.458, p=0.001), serum levels of BNP and ApoB (figure 2; r=-0.328, p=0.026) and serum levels of BNP and TC (figure 3; r=-0.383, p=0.010). There is a possibility that dietary EPA and DHA may modulate cardiac mitochondrial and autonomic nervous system dysfunction via fatty-acids-PPARs-PTEN-PI3K/Akt-SREBPs system and affect serum BNP levels indirectly.
CONCLUSION: BNP had significant negative correlation with ApoA2, ApoB and TC. The findings suggest that increasing serum levels of ApoA2, ApoB and TC may have an effect on improving heart function. But the mechanism is presently unclear.

Entities:  

Keywords:  CT scanning; Heart failure treatment; coronary artery disease; gene expression; hypertension

Year:  2012        PMID: 27326018      PMCID: PMC4898600          DOI: 10.1136/heartasia-2011-010042

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  52 in total

1.  Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression.

Authors:  Emiko Ogawa; Yoshihiko Saito; Koichiro Kuwahara; Masaki Harada; Yoshihiro Miyamoto; Ichiro Hamanaka; Noboru Kajiyama; Nobuki Takahashi; Takehiko Izumi; Rika Kawakami; Ichiro Kishimoto; Yoshihisa Naruse; Nozomu Mori; Kazuwa Nakao
Journal:  Cardiovasc Res       Date:  2002-02-01       Impact factor: 10.787

Review 2.  Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.

Authors:  W S Harris
Journal:  J Lipid Res       Date:  1989-06       Impact factor: 5.922

3.  Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis.

Authors:  Ximing Du; Ika Kristiana; Jenny Wong; Andrew J Brown
Journal:  Mol Biol Cell       Date:  2006-03-29       Impact factor: 4.138

4.  Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock.

Authors:  Toshiro Katayama; Hiroshi Nakashima; Chisa Takagi; Yukiharu Honda; Shin Suzuki; Katsusuke Yano
Journal:  Circ J       Date:  2005-01       Impact factor: 2.993

5.  Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.

Authors:  C M Ballantyne; J A Herd; L L Ferlic; J K Dunn; J A Farmer; P H Jones; J R Schein; A M Gotto
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

6.  B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.

Authors:  A Mark Richards; M Gary Nicholls; Eric A Espiner; John G Lainchbury; Richard W Troughton; John Elliott; Christopher Frampton; John Turner; Ian G Crozier; Timothy G Yandle
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic Akita mice.

Authors:  Ho-Jin Park; Yali Zhang; Chuang Du; C Michael Welzig; Christopher Madias; Mark J Aronovitz; Serban P Georgescu; Isaac Naggar; Bo Wang; Young-Bum Kim; Robert O Blaustein; Richard H Karas; Ronglih Liao; Clayton E Mathews; Jonas B Galper
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

8.  Suppression of hepatic fatty acid synthase by feeding alpha-linolenic acid rich perilla oil lowers plasma triacylglycerol level in rats.

Authors:  Hye-Kyeong Kim; Sungwon Choi; Haymie Choi
Journal:  J Nutr Biochem       Date:  2004-08       Impact factor: 6.048

9.  Transcriptional regulation of mitochondrial glycerophosphate acyltransferase is mediated by distal promoter via ChREBP and SREBP-1.

Authors:  Prajna Guha; Kawalpreet K Aneja; Rasheda Y Shilpi; Dipak Haldar
Journal:  Arch Biochem Biophys       Date:  2009-08-13       Impact factor: 4.013

10.  Cholesterol supports headgroup superlattice domain formation in fluid phospholipid/cholesterol bilayers.

Authors:  Brian Cannon; Anthony Lewis; Jennifer Metze; Visveswaran Thiagarajan; Mark W Vaughn; Pentti Somerharju; Jorma Virtanen; Juyang Huang; Kwan Hon Cheng
Journal:  J Phys Chem B       Date:  2006-03-30       Impact factor: 2.991

View more
  2 in total

1.  Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP.

Authors:  Annette Masuch; Maik Pietzner; Martin Bahls; Kathrin Budde; Gabi Kastenmüller; Stephanie Zylla; Anna Artati; Jerzy Adamski; Henry Völzke; Marcus Dörr; Stephan B Felix; Matthias Nauck; Nele Friedrich
Journal:  Cardiovasc Diabetol       Date:  2018-08-28       Impact factor: 9.951

2.  Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis.

Authors:  Francesco Spannella; Federico Giulietti; Marica Bordicchia; John C Burnett; Riccardo Sarzani
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.